FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) - The U.S. health regulator said on Wednesday it was expanding the medical device shortage list to include all ...

Using small-volume rather than standard-volume collection tubes to draw blood for laboratory testing may reduce the incidence of anemia and the need for red blood cell (RBC) transfusion in intensive ...

For the past month, the U.S. has been facing a dire lack of blood collection tubes, both due to the demands of the pandemic and global supply chain issues. This week, the National Coalition of STD ...

Pneumatic tube systems (PTS) have become an integral component of modern hospital infrastructure, enabling the rapid and reliable transport of blood samples from clinical areas to central laboratories ...

The plasma proteome is a rich source of potential biomarkers for diseases, such as cancer and neurodegenerative disorders. To assess these proteins, scientists commonly draw whole blood samples into ...

The cell-free DNA (cfDNA) blood collection tube market is ripe with opportunities driven by the rise in lifestyle-related ...

Novel innovations for stabilizing the plasma proteome in whole blood samples provide researchers with more confidence in their protein analysis. To reduce the preanalytical variability, scientists can ...

Jan 19 (Reuters) - The U.S. health regulator said on Wednesday it was expanding the medical device shortage list to include all blood specimen collection tubes due to supply challenges led by an ...